Celldex Therapeutics Inc (NASDAQ:CLDX)
| 20.80 Delayed Data As of 3:59pm ET |  +0.09 / +0.43%Today’s Change | 1.77 Today|||52-Week Range 30.17 | +18.72% Year-to-Date |
Latest CLDX News | Press Releases
| Could Celldex Be a Millionaire-Maker Stock? Apr 10 / MotleyFool.com - Paid Partner Content | ACADIA (ACAD) Gets CRL From FDA for Nuplazid sNDA, Shares Down Apr 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 20.71 |
| Today’s open | 20.30 |
| Day’s range | 19.71 - 20.85 |
| Volume | 34,241 |
| Average volume (3 months) | 744,143 |
| Market cap | $821.6M |
Data as of 3:59pm ET, 04/12/2021
Growth & Valuation
| Earnings growth (last year) | +75.78% |
| Earnings growth (this year) | +49.48% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -62.54% |
| P/E ratio | NM |
| Price/Sales | 9.05 |
| Price/Book | 3.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AWHAspira Women's Healt... | -0.24 | -3.85% |
| TRILTrillium Therapeutic... | -0.58 | -5.57% |
| ---- | ||
| VIVOMeridian Bioscience ... | -1.01 | -4.03% |
Data as of 3:59pm ET, 04/12/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $3.6M |
| Annual profit (last year) | -$50.9M |
| Net profit margin | -1,423.96% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hampton, New Jersey |
Forecasts
